Report: Winstanley Buys 25 Science Park in New Haven, Conn., for $14.5M from BMR
 
Winstanley Enterprises of Concord, Mass., has added to its life sciences portfolio in New Haven, Conn., by acquiring a ground lease for the 270,000-square-foot 25 Science Park (150 Munson St.) from BioMed Realty Trust for $14.5 million, according to a third-quarter office market report by the commercial real estate brokerage Colliers Dow & Condon.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.